IL1B and neoplasm: It is worth mentioning that the peptide LyeTx I-b significantly decreased the expression of IL-1β in tumor and lung tissues, with an increase in the levels ofIL-10 anti-inflammatory cytokines in primary tumor, as observed with other AMPs [81].